SURE

Article

Gomaa, M, Armstrong, Jane, Bobillon, B, Veal, G, Brancale, A, Redfern, C and Simons, C (2007) Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: Potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells. Bioorganic & Medicinal Chemistry, 16. pp. 8301-8313. ISSN 0968-0896

Armstrong, Jane, Taylor, G, Thomas, H, Boddy, A, Redfern, C and Veal, G (2007) Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo. British Journal of Cancer.

Corazzari, M, Lovat, P, Armstrong, Jane, Fimia, GM, Hill, D, Birch-Machin, M, Redfern, C and Piacentini, M (2007) Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. British Journal of Cancer, 96 (7). pp. 1062-1071. ISSN 1532-1827

Armstrong, Jane, Veal, G, Redfern, C and Lovat, P (2007) Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours. Apoptosis, 12. pp. 613-622. ISSN 1573-675X

Armstrong, Jane, Redfern, C and Veal, G (2005) 13-cis retinoic acid and isomerisation in paediatric oncology--is changing shape the key to success? Biochemical Pharmacology, 69 (9). pp. 1299-1306. ISSN Biochemical Pharmacology